What the documents list, and what they do not
We searched the US label, the EU summary of product characteristics and the Canadian monograph for terms such as cognition, memory, concentration and confusion as side effects. None appears as an adverse reaction of Saxenda®. Confusion and difficulty concentrating do appear, but only as signs of low blood sugar. [1][2][3] That leaves the reactions that sit closest to the feeling of a foggy head.
| Reaction | Saxenda® | Placebo | Source |
|---|---|---|---|
| Fatigue, adults | 7.5% | 4.6% | US Table 2 [1] |
| Asthenia (weakness), adults | 2.1% | 0.8% | US Table 2 [1] |
| Dizziness, adults | 6.9% | 5.0% | US Table 2 [1] |
| Dizziness, ages 12–17 | 10.4% | 3.2% | US Table 3 [1] |
| Insomnia, adults | 2.4% | 1.7% | US Table 2 [1]; mainly first 3 months [2][3] |
| Malaise (feeling generally unwell) | Uncommon | — | EU Table 4 [2] |
Why the first 12 weeks stand out
The US label and Canadian monograph say asthenia, fatigue, malaise, dysgeusia and dizziness were mainly reported within the first 12 weeks, often together with nausea, vomiting or diarrhoea. The Canadian text adds that most were mild to moderate and passed. [1][3] The EU summary similarly notes that dizziness occurs mainly in the first three months and that insomnia was mainly seen then too. [2]
This is the period of weekly dose increases, from 0.6 mg to 3 mg by week five, and of the steepest change in eating. [1] If a foggy feeling arrives alongside these effects and fades with them, that pattern matches what the documents describe, although none of them calls it brain fog.
What liraglutide research has measured
A pooled analysis of all phase 2 and 3a trials of liraglutide 3 mg for weight management, covering 3,384 people on the medicine and 1,941 on placebo, found similar rates of depression and anxiety in both groups, and questionnaire scores for depression improved slightly in both. [5] That does not address concentration directly, but it suggests mood, which strongly affects how clear-headed people feel, was not worse on average.
The ELAD trial gave daily liraglutide or placebo for 52 weeks to 204 people with mild to moderate Alzheimer’s disease and no diabetes. Liraglutide was generally safe and well tolerated, the main brain-imaging measure did not differ, and one executive-function score was better on liraglutide. [4] The population and purpose are very different from Saxenda® users, so it says little about everyday brain fog except that liraglutide did not harm thinking in that setting.
Drug-safety database studies have reported signals for lethargy and dizziness across GLP-1 medicines as a class, without separating liraglutide or establishing cause. [6]
Routes from a daily injection to a foggy head
- Low blood sugar, mainly in type 2 diabetes with insulin or a sulfonylurea: the Medication Guide lists confusion or drowsiness, dizziness, blurred vision and weakness among its signs, and the EU and Canadian leaflets add difficulty concentrating. [1][2][3] Teenagers in the Saxenda® trial reported symptomatic low blood sugar more often than on placebo. [1]
- Dehydration: nausea, vomiting or diarrhoea can lead to fluid loss, which the label links to kidney injury. [1] MedlinePlus lists irritability, confusion, dizziness and listlessness among the signs of severe dehydration. [8]
- Eating much less and early tiredness: the labels describe lower calorie intake as how liraglutide works, and fatigue and weakness as early reactions. [1]
- Sleep: insomnia is listed, and MedlinePlus names lack of sleep as a cause of confusion. [1][7]
- Lower blood pressure: hypotension-related reactions were reported in 1.1% on Saxenda® against 0.5% on placebo, which can bring light-headedness. [1]
Other causes worth considering
MedlinePlus lists many causes of muddled thinking: infections and fever, alcohol, other medicines, low oxygen from lung disease, head injury, nutritional deficiencies such as thiamine or vitamin B12, fluid and electrolyte imbalances and, more seriously, stroke or seizures. [7] It adds that confusion can come on quickly or slowly and often lasts only a short time, which is why the speed of onset matters when deciding how urgently to act. [7]
For driving, the Canadian monograph warns that low or high blood sugar can impair the ability to concentrate or react and advises against driving when dizzy; the EU summary asks for caution with driving if dizziness occurs. [2][3]
What the guidance describes
If you use insulin or a sulfonylurea with Saxenda®, the label asks that you know the signs of low blood sugar and how to treat it, and that you check your blood sugar before starting and during treatment. [1] The Medication Guide asks you to drink fluids to help avoid dehydration and to report nausea, vomiting or diarrhoea that does not go away. [1]
MedlinePlus advises booking an appointment if you have been experiencing confusion, and contacting a provider when someone who is not usually confused becomes so. [7] For fog that is mild and fading with the early side effects, writing down when it happens helps your prescriber judge the pattern.
Saxenda® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| Sudden confusion, especially in someone with diabetes, or confusion with fainting, fever, a fast pulse or cold clammy skin | Emergency services (911 / 112) | Emergency | MedlinePlus [7] |
| Confusion, shakiness, sweating or blurred vision if you use insulin or a sulfonylurea, or are a teenager on Saxenda® | Treat as possible low blood sugar as instructed; contact your care team | Today | Medication Guide [1] |
| Foggy, dizzy or listless with vomiting or diarrhoea and little urine | Your prescriber | Today | Medication Guide [1]; MedlinePlus [8] |
| Ongoing trouble thinking clearly, without an obvious trigger | Your doctor | At your next appointment | MedlinePlus [7] |
